Syandrez Prima Putra

Mr. Syandrez Prima Putra

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
SPSyandrez Prima Putra
Syandrez Prima Putra
THTaufik Hidayat
Taufik Hidayat
RZRahma Tsania Zhuhra
Rahma Tsania Zhuhra

28 June 2022 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SPSyandrez Prima Putra
Syandrez Prima Putra
APAndani Eka Putra
Andani Eka Putra
IAIndwiani Astuti
Indwiani Astuti
WAWidya Asmara
Widya Asmara
Background: Human papillomavirus type 16 (HPV16) is the most prevalent etiology of cervical cancer in Indonesian women. The L2 minor capsid protein has considerable potential as a broad-protective antigen target of the cervical cancer vaccine strategies, yet the data on L2 gene variation is still minimal. In this research, we determined the variations of the HPV16 L2 gene sequences in Indonesian cervical cancer specimens. Methods: We cross-sectionally observed 23 DNA isolates of HPV16 positive cervical cancer specimens stored in the laboratory of the Center for Diagnostic and Research on Infectious Diseases (PDRPI Lab), Faculty of Medicine, Universitas Andalas, Padang, Indonesia. We detected and amplified the HPV16 L2 gene sequences in the samples, followed by sequencing, DNA alignment, single nucleotide polymorphisms (SNPs) analysis, and phylogenetic tree reconstruction. Results: As many as 35 SNPs were found, consist of 18 synonymous SNPs (sSNPs) and 17 non-synonymous SNPs (nsSNPs). Amino acid variations were mostly detected at S269P (100%) and L330F (43.48%) with no variation in the immuno-protective region near L2 N-terminus. A total of 5 HPV16 phylogenetic sub-lineages were found closely related to A1 (n=5), A2 (n=12), A3 (n=2), A4 (n=3), and C (n=1). Conclusion: The variations of HPV16 L2 gene sequences are mainly located in the central region of the L2 sequences, and the cross-protective region near the L2 N-terminus is remarkably conserved. This study should enhance the information about HPV16 L2 gene variation in Indonesia.

11 March 2025 in Asian Pacific Journal of Tropical Medicine
Verified
Journal Article
Open access
SYSatya Wydya Yenny
Satya Wydya Yenny
RLRini Gusya Liza
Rini Gusya Liza
SPSyandrez Prima Putra
Syandrez Prima Putra
RARizkia Chairani Asri
Rizkia Chairani Asri
DJDwi Sabtika Julia
Dwi Sabtika Julia
NWNoverika Windasari
Noverika Windasari
Objective: To assess public knowledge, attitudes, and behaviours regarding same-sex sexual intercourse (SSI) in relation to HIV/AIDS transmission prevention, especially in an inclusive cultural and religious country like Indonesia, beyond established prevention methods like safe sex practices and Pre-Exposure Prophylaxis (PrEP). Methods: We collected cross-sectional online survey data from the Indonesian 18 years or older population in December 2021 and August 2022. We determined participants' knowledge, attitude, and behaviour scores toward SSI and HIV/AIDS prevention. We critically explored each score and used multiple linear regression to identify the predictive factors. Results: The survey included 386 adults [median age (IQR): 22 (20-35) years]. The median (IQR) score was 90/100 (80-100) for knowledge, 43/50 (39-46) for attitude and 70/70 (70-70) for behaviour. The number of men who had sex with men (MSM) was 7/129 (5.4%). Male sex, non-MSM, higher knowledge, and higher attitude scores were positively associated with higher behaviour scores (P<0.001). Conclusions: This study highlights the need for inclusive HIV/AIDS prevention strategies that respect cultural and religious values, reduce stigma, and improve healthcare access, while aligning with international guidelines and scientific evidence

31 May 2023 in Journal of Preventive Medicine and Public Health
Verified
Journal Article
Open access
PDF file
DRDidan Ariadapa Rahadi
Didan Ariadapa Rahadi
EYElfira Yusri
Elfira Yusri
SPSyandrez Prima Putra
Syandrez Prima Putra
RSRima Semiarty
Rima Semiarty
DPDian Pertiwi
Dian Pertiwi
CICimi Ilmiawati
Cimi Ilmiawati
Objectives: The second wave of coronavirus disease 2019 (COVID-19) cases in Indonesia, during which the Delta variant predominated, took place after a vaccination program had been initiated in the country. This study was conducted to assess the impact of COVID-19 vaccination on unfavorable clinical outcomes including hospitalization, severe COVID-19, intensive care unit (ICU) admission, and death using a real-world model.Methods: This single-center retrospective cohort study involved patients with COVID-19 aged ≥18 years who presented to the COVID-19 emergency room at a secondary referral teaching hospital between June 1, 2021 and August 31, 2021. We used a binary logistic regression model to assess the effect of COVID-19 vaccination on unfavorable clinical outcomes, with age, sex, and comorbidities as confounding variables.Results: A total of 716 patients were included, 32.1% of whom were vaccinated. The elderly participants (≥65 years) had the lowest vaccine coverage among age groups. Vaccination had an effectiveness of 50% (95% confidence interval [CI], 25 to 66) for preventing hospitalization, 97% (95% CI, 77 to 99) for preventing severe COVID-19, 95% (95% CI, 56 to 99) for preventing ICU admission, and 90% (95% CI, 22 to 99) for preventing death. Interestingly, patients with type 2 diabetes had a 2-fold to 4-fold elevated risk of unfavorable outcomes.Conclusions: Among adults, COVID-19 vaccination has a moderate preventive impact on hospitalization but a high preventive impact on severe COVID-19, ICU admission, and death. The authors suggest that relevant parties increase COVID-19 vaccination coverage, especially in the elderly population.

8 October 2023 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
EYElfira Yusri
Elfira Yusri
SPSyandrez Prima Putra
Syandrez Prima Putra
LMLiganda Endo Mahata
Liganda Endo Mahata
APAndani Eka Putra
Andani Eka Putra
Limited evidence exists on whether initial viral load and patient characteristics can predict unfavorable outcomes in future outbreaks of coronavirus disease 2019 (COVID-19). This retrospective cohort study examined the relationship between the initial viral load, patient characteristics, and outcomes during the second-wave COVID-19 outbreak in West Sumatra, Indonesia. We analyzed the COVID-19 patients admitted to a secondary hospital between the 1 June 2021 and the 31 August 2021. The initial viral load was determined using the real-time quantitative-polymerase chain reaction (RT-qPCR) cycle threshold (Ct) value, categorized as low (LIVL, Ct > 20) or high (HIVL, Ct ≤ 20). Multivariate logistic regression was used to assess the relationship between the initial viral load, age, sex, vaccination status, comorbidities, and outcomes, including disease severity, hospital stay length, ICU admission, invasive ventilation, and in-hospital mortality. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used to assess the diagnostic performance of the initial Ct values in predicting COVID-19 outcomes. The study included 373 patients (median age [range]: 48 [0–94]; male: 40.21%; HIVL: 34.85%; unvaccinated: 86.06%; comorbidities: 52.01%). The HIVL patients significantly had a lower risk of developing severe/critical outcomes (OR: 0.506; 95% CI: 0.310–0.825; p = 0.006) and needing invasive ventilation (OR: 0.290; CI: 0.098–0.854; p = 0.025). The Ct value used to indicate severe/critical outcomes was 23.57. More severe outcomes were significantly observed in LIVL patients, those aged >60 years, males, unvaccinated individuals, and those with comorbidities. This study emphasizes the importance of primary prevention, early screening, and immediate care for COVID-19 in saving lives.

1 January 2022 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
LMLiganda Endo Mahata
Liganda Endo Mahata
MLMutia Lailani
Mutia Lailani
SRSm Rezvi
Sm Rezvi
SPSyandrez Prima Putra
Syandrez Prima Putra
APAndani Eka Putra
Andani Eka Putra
BACKGROUND: Asymptomatic COVID-19 cases are potential for SARS-CoV-2 outbreaks source, yet the feasible predictive factors are unclear. AIM: Our study aimed to determine the age and sex differences in the presence of COVID-19 clinical symptoms at the initial diagnosis. METHODS: We examined the results of individual first-time quantitative reverse transcription-polymerase chain reaction (q-RT-PCR) of 19,588 COVID-19 positive cases registered at the Center for Diagnostic and Research on Infectious Disease Laboratory (PDRPI Lab), Faculty of Medicine, Universitas Andalas, Padang, Indonesia, from April 2020 to December 2020. Asymptomatic cases were those who had no symptoms at the initial confirmation while symptomatic had. The differences of age (classified into five age groups) and sex (female or male) were evaluated in both cases to see their significance. RESULTS: A total of 12,790 (65.30%) of COVID-19 cases were asymptomatic. The COVID-19 patients had average age (mean ± SD) of 37.12 ± 17.22 years old (y.o.). Younger adults (20–39 y.o.; 42.01%; average age (mean ± SD) 29.51 ± 5.52 y.o.) were the most affected, followed by adults (40–59 y.o.; 32.09%; average age (mean ± SD) 49.29 ± 5.63 y.o.), children (≤19 years; 15.30%; average age (mean ± SD) 11.82 ± 5.70 y.o.), older adults (60–79 years; 9.90%; average age (mean ± SD) 65.76 ± 4.86 y.o.), and elderly (≥80 years; 0.71%; average age (mean ± SD) 83.31 ± 3.65 y.o.). Female cases (53.23%; average age (mean ± SD) 34.92 ± 16.57 y.o.) were more prevalent than males (46.77%; average age (mean ± SD) 41.26 ± 17.65 y.o.), with a significant mean age difference (P < 0.001). The odds of being asymptomatic were increased in the younger age group (adults OR as the reference; children OR 0.471, 95% CI 0.426–0.519; younger adults OR 0.68, 95% CI 0.639–0.734; older adults OR 1.766, 95% CI 1.594–1.957; and elderly OR 1.981, 95% CI 1.412–2.780; P < 0.001). Females were more likely than males to be asymptomatic (OR 1.105, 95% CI 1.042–1.172). Conclusions: The younger age and the female sex are associated with asymptomatic COVID-19 cases in the earliest molecular diagnosis.